AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $475.7M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.25pm 06/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $7.66 | Day High | $7.66 | Day Low | $7.36 | |||
| Daily Volume | 93856 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $7.42 | 1000 | 0 | $7.51 | 1455 | |
Directors & Senior Management
| Ms. Abby Perry | Chief People Officer |
| Mr. Bradley David Board | Chief Operating Officer |
| Mr. Giovanni Rizzo | Independent Non-Executive Director |
| Mr. Graham Blackett | Additional Company Secretary |
| Mr. Jatin Khosla | Chief Financial Officer |
| Ms. Marina Avisar | President of Stride |
| Mr. Michael Martin Malone | Independent Non-Executive Director |
| Mr. Mike Veverka | Founder, MD, CEO & Executive Director |
| Prof. Sharon Anne Christensen | Independent Non-Executive Director |
| Ms. Susan Margaret Forrester | Independent Chair of the Board |
| Mr. Tam Watson | Head of Operations - UK |
| Mr. Xavier Robert Bergade | Chief Technology Officer |
Data source: ADVFN
